GlaxoSmithKline PLC

53.60

-0.1700-0.32%

Volume:2.54M

Turnover:136.37M

Market Cap:108.98B

PE:14.35

High:53.99

Open:53.75

Low:53.38

Close:53.77

52wk High:61.70

52wk Low:32.38

Shares:2.03B

Float Shares:1.95B

Volume Ratio:0.56

T/O Rate:0.13%

Dividend:1.76

Dividend Rate:3.29%

EPS(TTM):3.74

EPS(LYR):3.74

ROE:43.31%

ROA:9.79%

PB:4.98

PE(LYR):14.35

Loading ...

Overview Company News Filings

Company Profile

Company Name:

GlaxoSmithKline PLC

Exchange:

NYSE

Establishment Date:

1715

Employees:

66841

Office Location:

79 New Oxford Street,London,Greater London,United Kingdom

Website:

http://www.gsk.com

Zip Code:

WC1A 1DG

Phone:

44 20 8047 5000

Fax:

- -

Introduction:

GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.

Directors

Name

Position

Luke Miels

Chief Executive Officer and Director

Anne Beal